Craig-Hallum Initiates Coverage On PMV Pharma with Buy Rating, Announces Price Target of $6
Benzinga Newsdesk 2 years ago
NewsPrice TargetInitiationAnalyst Ratings
Craig-Hallum analyst Albert Lowe initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target of $6.
Craig-Hallum analyst Albert Lowe initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target of $6.